We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
HSTM icon
126
HealthStream
HSTM
$929M
$929M $30.36 2.19%
CRVS icon
127
Corvus Pharmaceuticals
CRVS
$919M
$919M $10.93 5.12%
BVS icon
128
Bioventus
BVS
$919M
$919M $13.45 1.32%
CBLL
129
CeriBell Inc
CBLL
$906M
$906M $23.61 3.2%
ABUS icon
130
Arbutus Biopharma
ABUS
$903M
$903M $4.56 4.6%
SLBT
131
SL Science Holding Ltd
SLBT
$897M
$897M $1.60 5.88%
SGP
132
SpyGlass Pharma
SGP
$886M
$886M $26.50 1.92%
RIGL icon
133
Rigel Pharmaceuticals
RIGL
$877M
$877M $46.97 2.45%
JBIO
134
Jade Biosciences
JBIO
$876M
$876M $13.77 1.99%
AHG
135
Akso Health Group
AHG
$874M
$874M $1.02 13.3%
ARDX icon
136
Ardelyx
ARDX
$873M
$873M $3.38 1.17%
HELP
137
Cybin Inc
HELP
$870M
$870M $11.91 3.09%
SANA icon
138
Sana Biotechnology
SANA
$865M
$865M $2.89 1.03%
RSPH icon
139
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$853M
$853M $36.58 1.16%
DNA icon
140
Ginkgo Bioworks
DNA
$842M
$842M $12.50 2.57%
SIBN icon
141
SI-BONE Inc
SIBN
$825M
$825M $18.41 2.07%
OBX
142
Obsidian Therapeutics
OBX
$823M
$823M $13.32 2.99%
IVA
143
Inventiva
IVA
$817M
$817M $3.46 6.23%
ATTO
144
Attovia Therapeutics
ATTO
$812M
$812M $17.79 3.79%
LXRX icon
145
Lexicon Pharmaceuticals
LXRX
$810M
$810M $1.82 3.19%
INMD icon
146
InMode
INMD
$808M
$808M $14.05 0.85%
AVTX icon
147
Avalo Therapeutics
AVTX
$802M
$802M $14.95 2.48%
VREX icon
148
Varex Imaging
VREX
$785M
$785M $18.49 0.22%
ANNX icon
149
Annexon
ANNX
$781M
$781M $4.12 2.6%
PACB icon
150
Pacific Biosciences
PACB
$780M
$780M $2.51 5.91%

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 324 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $279B.

The largest by market cap are Biohaven (BHVN) at $1.98B, UroGen Pharma (URGN) at $1.98B and Nuvation Bio (NUVB) at $1.95B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.